Uppsala professor warns TBE vaccine may need updating

TBE cases in Sweden have tripled over ten years despite rising vaccinations. Åke Lundkvist, professor of virology at Uppsala University, suspects the virus may have changed, reducing vaccine effectiveness. Researchers are now analyzing 12,000 ticks to investigate.

The number of reported TBE cases in Sweden has risen sharply over the past ten years. According to Folkhälsomyndigheten, cases increased from 238 in 2016 to 504 in 2025, with peaks like 595 in 2023 and a low of 274 in 2020. Vaccinations have risen at a similar pace.

Åke Lundkvist, professor of virology at Uppsala University, describes the trend as suspicious. "Something is fishy," he told SVT Nyheter. He suggests the vaccine may be losing effectiveness if the TBE virus has mutated. "The vaccine can become less effective if the virus causing the infection changes," Lundkvist explained.

To clarify, around 12,000 ticks collected by the Swedish public are being sent to Statens veterinärmedicinska anstalt (SVA). They will be analyzed in collaboration with Uppsala University's Zoonoscentret to compare current virus strains with those from previous years and the basis for existing vaccines.

Lundkvist stresses the need for vaccination. "Absolutely not [skip getting vaccinated], the vaccine works and it is the only important remedy we have today. We will find out if it can be even better," he said. The research aims to rule out other causes for the rise.

Articles connexes

Illustration of a crowded Swedish hospital amid flu surge, with rising case stats displayed.
Image générée par IA

Number of influenza cases surges in Sweden

Rapporté par l'IA Image générée par IA

Influenza has truly arrived in Sweden. In the first week of the year, 2,131 cases were confirmed, a 22 percent increase from the end of the previous week. The spread is assessed as medium-high level, according to the Public Health Agency.

Flu cases in Sweden have doubled every week since mid-November, driven by the new K variant of the influenza virus. The Public Health Agency reports a rapid increase, with cases rising from 403 to 808 in one week. Severe cases, including deaths and intensive care admissions, have also risen from low levels.

Rapporté par l'IA

Researchers in China have developed a potent antibody that could combat severe fever with thrombocytopenia syndrome (SFTS), a tick-borne disease with a mortality rate of up to 30 percent. The discovery offers new hope for tackling this growing threat in East Asia.

The meningitis outbreak in Canterbury, Kent, UK, has escalated with 29 infections and two deaths, prompting mass vaccinations and antibiotics distribution. Authorities warn of possible spread beyond Kent, while Swedish experts advise vigilance.

Rapporté par l'IA Vérifié par des faits

Des scientifiques de l’Université du Queensland ont capturé les premières images 3D quasi-atomiques à haute résolution du virus de la fièvre jaune, détaillant comment la surface de la souche vaccinale utilisée de longue date diffère des souches virulentes causant des maladies. Ce travail éclaire la manière dont le virus est reconnu par le système immunitaire et pourrait soutenir des vaccins améliorés pour la fièvre jaune et les maladies liées transmises par les moustiques.

Des chercheurs de l'UC San Francisco ont découvert des preuves montrant comment le virus Epstein-Barr peut déclencher des réponses immunitaires chez les patients atteints de sclérose en plaques. L'étude révèle des niveaux élevés de cellules immunitaires ciblant le virus dans les systèmes nerveux de ces patients. Ces résultats, publiés dans Nature Immunology, suggèrent de nouvelles voies thérapeutiques potentielles en ciblant le virus.

Rapporté par l'IA

Les infections à rougeole aux États-Unis ont atteint leur niveau le plus élevé en plus de trois décennies l'an dernier, avec 2 242 cas confirmés. Une flambée en Caroline du Sud, qui a infecté plus de 600 personnes depuis octobre, menace de surpasser un incident majeur dans l'Ouest du Texas. Ce développement annonce une autre année difficile pour la santé publique.

 

 

 

Ce site utilise des cookies

Nous utilisons des cookies pour l'analyse afin d'améliorer notre site. Lisez notre politique de confidentialité pour plus d'informations.
Refuser